{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:58:14Z","timestamp":1773154694743,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011010","name":"European SocieTy for Radiotherapy and Oncology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.ctro.2023.100684","type":"journal-article","created":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T11:33:05Z","timestamp":1695468785000},"page":"100684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy"],"prefix":"10.1016","volume":"43","author":[{"given":"Piet","family":"Dirix","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Dal Pra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Carrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesare","family":"Cozzarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Fonteyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pirus","family":"Ghadjar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"Gomez-Iturriaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina-Sophie","family":"Schmidt-Hegemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Panebianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Almudena","family":"Zapatero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Wiegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctro.2023.100684_b0005","article-title":"ESTRO ACROP guideline on prostate bed delineation for postoperative radiotherapy in prostate cancer","volume":"41","author":"Dal Pra","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ctro.2023.100684_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.775387","article-title":"Targeting local recurrence after surgery with MRI imaging for prostate cancer in the setting of salvage radiation therapy","volume":"12","author":"Renard-Penna","year":"2022","journal-title":"Front Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2023.100684_b0015","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.euo.2021.01.003","article-title":"Prostate Magnetic Resonance Imaging for local Recurrence Reporting (PI-RR): international consensus-based guidelines on multiparametric magnetic resonance imaging for prostate cancer recurrence after radiation therapy and radical prostatectomy","volume":"4","author":"Panebianco","year":"2021","journal-title":"Eur Urol Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2023.100684_b0020","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1148\/radiol.212252","article-title":"Diagnostic accuracy and observer agreement of the MRI prostate imaging for recurrence reporting assessment score","volume":"304","author":"Pecoraro","year":"2022","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.ctro.2023.100684_b0025","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/0284186X.2016.1223342","article-title":"Proposal for magnetic resonance imaging-guided salvage radiotherapy for prostate cancer","volume":"56","author":"Dirix","year":"2017","journal-title":"Acta Oncol"},{"issue":"6","key":"10.1016\/j.ctro.2023.100684_b0030","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.eururo.2017.11.012","article-title":"Multiparametric magnetic resonance imaging is an independent predictor of salvage radiotherapy outcomes after radical prostatectomy","volume":"73","author":"Sharma","year":"2018","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ctro.2023.100684_b0035","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.euf.2017.11.001","article-title":"Imaging for detection of locoregional recurrences in biochemical progression after radical prostatectomy \u2013 a systematic review","volume":"5","author":"Sandgren","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"2","key":"10.1016\/j.ctro.2023.100684_b0040","first-page":"106","article-title":"Accuracy of 68Ga-PSMA-11 PET\/CT and multiparametric MRI for the detection of local tumor and lymph node metastases in early biochemical recurrence of prostate cancer","volume":"10","author":"Radzina","year":"2020","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"10","key":"10.1016\/j.ctro.2023.100684_b0045","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1007\/s00259-020-04718-w","article-title":"Interobserver variability, detection rate, and lesion patterns of 68Ga-PSMA-11-PET\/CT in early-stage biochemical recurrence of prostate cancer after radical prostatectomy","volume":"47","author":"Miksch","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"21","key":"10.1016\/j.ctro.2023.100684_b0050","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.3390\/cancers13215564","article-title":"A prospective study assessing the post-prostatectomy detection rate of a presumed local failure at mpMRI with either 64CuCl2 or 64CuPSMA PET\/CT","volume":"12","author":"Faiella","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ctro.2023.100684_b0055","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.eururo.2020.09.046","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II \u2013 2020 update: treatment of relapsing and metastatic prostate cancer","volume":"79","author":"Cornford","year":"2021","journal-title":"Euro Urol"},{"key":"10.1016\/j.ctro.2023.100684_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euros.2021.09.007","article-title":"A 5-year contemporary nationwide evolution of the radical prostatectomy landscape","volume":"34","author":"Ploussard","year":"2021","journal-title":"Eur Urol Open Sci"},{"issue":"12","key":"10.1016\/j.ctro.2023.100684_b0065","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/pros.24181","article-title":"Twenty-year trends in prostate cancer stage and grade migration in a large contemporary German radical prostatectomy cohort","volume":"81","author":"W\u00fcrnschimmel","year":"2021","journal-title":"Prostate"},{"issue":"6","key":"10.1016\/j.ctro.2023.100684_b0070","doi-asserted-by":"crossref","first-page":"e2112214","DOI":"10.1001\/jamanetworkopen.2021.12214","article-title":"Time trends in use of radical prostatectomy by tumor risk and life expectancy in a national Veterans affairs cohort","volume":"4","author":"Vaculik","year":"2021","journal-title":"JAMA Network Open"},{"issue":"23","key":"10.1016\/j.ctro.2023.100684_b0075","doi-asserted-by":"crossref","first-page":"8754","DOI":"10.1002\/cam4.3482","article-title":"Trends in prostatectomy utilization: increasing upfront prostatectomy and postprostatectomy radiotherapy for high-risk prostate cancer","volume":"9","author":"Kaps","year":"2020","journal-title":"Cancer Med"},{"issue":"1","key":"10.1016\/j.ctro.2023.100684_b0080","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00066-017-1172-3","article-title":"Salvage radiotherapy for macroscopic local recurrences after radical prostatectomy : a national survey on patterns of practiceSalvage-Radiotherapie bei makroskopischen Lokalrezidiven nach radikaler Prostatektomie: Nationale Umfrage zu Behandlungsmustern","volume":"194","author":"Dal Pra","year":"2018","journal-title":"Strahlentherapie und Onkologie"},{"issue":"1","key":"10.1016\/j.ctro.2023.100684_b0085","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.radonc.2014.06.017","article-title":"Four years with FALCON \u2013 an ESTRO educational project: achievements and perspectives","volume":"112","author":"Eriksen","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ctro.2023.100684_b0090","unstructured":"https:\/\/www.krebsgesellschaft.de\/gcs\/german-cancer-society\/guidelines.html."},{"key":"10.1016\/j.ctro.2023.100684_b0095","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.897700","article-title":"Reliability of gradient-based segmentation for measuring metabolic parameters influenced by uptake time on 18F-PSMA-1007 PET\/CT for prostate cancer","volume":"12","author":"Lau","year":"2022","journal-title":"Front Oncol"},{"issue":"5","key":"10.1016\/j.ctro.2023.100684_b0100","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1607529","article-title":"Radiation with or without anti-androgen therapy in recurrent prostate cancer","volume":"376","author":"Shipley","year":"2017","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ctro.2023.100684_b0105","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/S1470-2045(19)30486-3","article-title":"Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomized trial","volume":"20","author":"Carrie","year":"2019","journal-title":"Lancet Oncol"},{"issue":"10338","key":"10.1016\/j.ctro.2023.100684_b0110","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1016\/S0140-6736(21)01790-6","article-title":"The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology\/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial","volume":"399","author":"Pollack","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ctro.2023.100684_b0115","doi-asserted-by":"crossref","unstructured":"Schmidt-Hegemann N.-S., Zamboglou C., Mason M., et al. ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancer. Radiother Oncol 2023; E-pub ahead of print (doi: 10.1016\/j.radonc.2023.109544).","DOI":"10.1016\/j.radonc.2023.109544"},{"issue":"1","key":"10.1016\/j.ctro.2023.100684_b0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00259-018-4066-4","article-title":"68Ga-PSMA-11 PET\/CT in prostate cancer patients with biochemical recurrence after radical prostatectomy and PSA < 0.5 ng\/ml. Efficacy and impact on treatment strategy","volume":"46","author":"Farolfi","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"10.1016\/j.ctro.2023.100684_b0125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41391-022-00544-3","article-title":"The impact of PSMA PET on the treatment and outcomes of men with biochemical recurrence of prostate cancer: a systematic review and meta-analysis","volume":"26","author":"Pozdnyakov","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"10.1016\/j.ctro.2023.100684_b0130","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.ijrobp.2020.04.011","article-title":"A systematic review of contouring guidelines in radiation oncology: an analysis of frequency, methodology, and delivery of consensus recommendations","volume":"107","author":"Lin","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2023.100684_b0135","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/bju.14924","article-title":"Stereotactic radiotherapy for prostate bed recurrence after prostatectomy, a multicentric series","volume":"125","author":"Francolini","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.ctro.2023.100684_b0140","doi-asserted-by":"crossref","unstructured":"Francolini G., Garlatti P., Di Cataldo V., et al. Three months\u2019 PSA and toxicity from a prospective trial investigating STereotactic sAlvage Radiotherapy for macroscopic prostate bed Recurrence after prostatectomy\u2014STARR (NCT05455736). Cancers (Basel) 2023; 15(3): 992.","DOI":"10.3390\/cancers15030992"},{"issue":"3","key":"10.1016\/j.ctro.2023.100684_b0145","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3390\/cancers14030696","article-title":"Stereotactic radiotherapy after radical prostatectomy in patients with prostate cancer in the adjuvant or salvage setting: a systematic review","volume":"14","author":"Schr\u00f6der","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/j.ctro.2023.100684_b0150","doi-asserted-by":"crossref","first-page":"9349","DOI":"10.3390\/curroncol29120733","article-title":"Acute toxicity and quality of life in a post-prostatectomy ablative radiation therapy (POPART) multicentric trial","volume":"29","author":"Lucchini","year":"2022","journal-title":"Curr Oncol"},{"issue":"7","key":"10.1016\/j.ctro.2023.100684_b0155","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.20.02873","article-title":"Focal boost to the intraprostatic tumor in external beam radiotherapy for patients with localized prostate cancer: results from the FLAME randomized phase III trial","volume":"39","author":"Kerkmeijer","year":"2021","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ctro.2023.100684_b0160","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.eururo.2021.12.012","article-title":"Patterns of failure following external beam radiotherapy with or without an additional focal boost in the randomized controlled FLAME trial for localized prostate cancer","volume":"82","author":"Groen","year":"2022","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.ctro.2023.100684_b0165","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ijrobp.2019.09.047","article-title":"Toxicity and biochemical outcomes of dose-intensified postoperative radiation therapy for prostate cancer: results of a randomized phase III trial","volume":"106","author":"Qi","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ctro.2023.100684_b0170","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.eururo.2021.05.033","article-title":"Dose-intensified versus conventional-dose salvage radiotherapy for biochemical recurrent prostate cancer after prostatectomy: the SAKK 09\/10 randomized phase 3 trial","volume":"80","author":"Ghadjar","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.ctro.2023.100684_b0175","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.723536","article-title":"A multi-institutional analysis of prostate cancer patients with or without 68Ga-PSMA PET\/CT prior to salvage radiotherapy of the prostatic fossa","volume":"11","author":"Schmidt-Hegemann","year":"2021","journal-title":"Front Oncol"},{"issue":"1058","key":"10.1016\/j.ctro.2023.100684_b0180","doi-asserted-by":"crossref","first-page":"20150579","DOI":"10.1259\/bjr.20150579","article-title":"Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-choline for guiding target volume delineation","volume":"89","author":"Wahart","year":"2016","journal-title":"Br J Radiol"},{"issue":"2","key":"10.1016\/j.ctro.2023.100684_b0185","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/COC.0000000000000130","article-title":"Results of dose-adapted salvage radiotherapy after radical prostatectomy based on an endorectal MRI target definition model","volume":"40","author":"Zilli","year":"2017","journal-title":"Am J Clin Oncol"},{"issue":"11","key":"10.1016\/j.ctro.2023.100684_b0190","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s12094-019-02084-0","article-title":"Macroscopic locoregional relapse from prostate cancer: which role for salvage radiotherapy?","volume":"21","author":"Bruni","year":"2019","journal-title":"Clin Transl Oncol"},{"issue":"2","key":"10.1016\/j.ctro.2023.100684_b0195","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2967\/jnumed.118.212563","article-title":"Outcome after PSMA PET\/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysis","volume":"60","author":"Schmidt-Hegemann","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.ctro.2023.100684_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.669261","article-title":"Salvage radiotherapy for macroscopic local recurrence following radical prostatectomy","volume":"11","author":"Zaine","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ctro.2023.100684_b0205","doi-asserted-by":"crossref","unstructured":"Lee S.U., Cho K.H., Kim J.H., et al. Clinical outcome of salvage radiotherapy for locoregional clinical recurrence after radical prostatectomy. Technol Cancer Res Treat 2021; 20: 15330338211041212.","DOI":"10.1177\/15330338211041212"},{"key":"10.1016\/j.ctro.2023.100684_b0210","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.715020","article-title":"Feasibility and outcome of PSMA-PET-based dose-escalated salvage radiotherapy versus conventional salvage radiotherapy for patients with recurrent prostate cancer","volume":"11","author":"Vogel","year":"2021","journal-title":"Front Oncol"},{"issue":"19","key":"10.1016\/j.ctro.2023.100684_b0215","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.3390\/cancers14194956","article-title":"Dose-escalated salvage radiotherapy for macroscopic local recurrence of prostate cancer in the prostate-specific membrane antigen positron emission tomography era","volume":"14","author":"Tamihardja","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/j.ctro.2023.100684_b0220","doi-asserted-by":"crossref","first-page":"252.e1","DOI":"10.1016\/j.urolonc.2022.12.001","article-title":"Treatment outcomes of postoperative ultra-hypofractionated stereotactic body radiotherapy in prostate cancer","volume":"41","author":"Ozyigit","year":"2023","journal-title":"Urol Oncol"},{"issue":"1","key":"10.1016\/j.ctro.2023.100684_b0225","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijrobp.2022.08.041","article-title":"Quality-of-life outcomes and toxicity profile among patients with localized prostate cancer after radical prostatectomy treated with stereotactic body radiation: the SCIMITAR multicentre phase 2 trial","volume":"115","author":"Ma","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ctro.2023.100684_b0230","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.euo.2023.02.013","article-title":"Prostatectomy bed image-guided dose-escalated salvage radiotherapy (SPIDER): an international multicenter retrospective study","volume":"6","author":"Benziane-Ouaritini","year":"2023","journal-title":"Eur Urol Oncol"}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082300109X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240563082300109X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:12:03Z","timestamp":1762503123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240563082300109X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":46,"alternative-id":["S240563082300109X"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100684","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ESTRO ACROP consensus recommendation on the target volume definition for radiation therapy of macroscopic prostate cancer recurrences after radical prostatectomy","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2023.100684","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100684"}}